Clinical trials
Phase 3 Hemorrhagic Disorders trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 2 |
| Takeda | 2 |
| BioMarin Pharmaceutical | 1 |
| Kedrion S.p.A. | 1 |
| Swedish Orphan Biovitrum | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 7 |
| Hemorrhagic Disorders | 7 |
| Blood Coagulation Disorders | 4 |
| Autoimmune Diseases | 3 |
| Blood Coagulation Disorders, Inherited | 3 |
| Blood Platelet Disorders | 3 |
| Coagulation Protein Disorders | 3 |
| Genetic Diseases, Inborn | 3 |
| Hemophilia A | 3 |
| Purpura, Thrombocytopenic, Idiopathic | 3 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.